چکیده مقاله
Antiphospholipid syndrome is the most frequently acquired risk factor for a treatable cause of recurrent abortion, stillbirth, preeclampsia, intrauterine death, premature birth, and fetal growth restriction The purpose of this study was to review current literature about the antiphospholipid syndrome as a risk factor for preeclampsia Systematic literature searches using pre specified terms were performed on PubMed, Ovid EMBASE, Ovid Medline, Cochrane library, Clinicaltrials gov, and Web of Science from database inception dates to Jun 2022 Antiphospholipid syndrome, in relation to pregnancy, is characterized by the presence of antiphospholipid autoantibodies in association with repeated fetal loss and complications such as preeclampsia retarded fetal growth, or placental insufficiency
کلیدواژهها
نویسندگان
Mahmood Abedinzade
Associate Professor, Medical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran
Zahra Bostani Khalesi
Associate Professor, Department of Midwifery, School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran
شیوه ارجاع
Abedinzade, Mahmood and Bostani Khalesi, Zahra,1401,Antiphospholpid Syndrome: Risk Factor for Preeclampsia,7th International Conference on New Findings in Midwifery, Obstetrics, Gynecology and Infertility
ارائهشده در
مجموعه مقالات هفتمین کنفرانس بین المللی یافته های نو در مامایی،زنان ،زایمان و نازایی10 تیر 1401